| Integrative Therapies Walla Walla, Llc | |
|
19 E Birch St Ste 104 Walla Walla WA 99362-3205 | |
| (773) 349-6778 | |
| Not Available |
| Full Name | Integrative Therapies Walla Walla, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 19 E Birch St Ste 104, Walla Walla, Washington |
| Authorized Official Name and Position | Elise Oconnell (OWNER) |
| Authorized Official Contact | 7733496778 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Integrative Therapies Walla Walla, Llc 19 E Birch St Ste 104 Walla Walla WA 99362-3205 Ph: (773) 349-6778 | Integrative Therapies Walla Walla, Llc 19 E Birch St Ste 104 Walla Walla WA 99362-3205 Ph: (773) 349-6778 |
| NPI Number | 1609331206 |
|---|---|
| Provider Enumeration Date | 02/07/2019 |
| Last Update Date | 07/26/2019 |
| Medicare PECOS PAC ID | 7517296684 |
|---|---|
| Medicare Enrollment ID | O20190916001352 |
News Archive
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer.
Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.
Oncotarget published "Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells" which reported that this study aimed to investigate whether Hepatocellular Cancer (HCC) cells cultured in more native conditions have an altered phenotype and drug sensitivity compared to those cultured in standard conditions.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609331206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Elise K Oconnell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1548592009 PECOS PAC ID: 6305020363 Enrollment ID: I20190916001877 |
News Archive
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer.
Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.
Oncotarget published "Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells" which reported that this study aimed to investigate whether Hepatocellular Cancer (HCC) cells cultured in more native conditions have an altered phenotype and drug sensitivity compared to those cultured in standard conditions.
› Verified 5 days ago
News Archive
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer.
Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.
Oncotarget published "Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells" which reported that this study aimed to investigate whether Hepatocellular Cancer (HCC) cells cultured in more native conditions have an altered phenotype and drug sensitivity compared to those cultured in standard conditions.
› Verified 5 days ago
Chiildrens Home Society Of Washington Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1612 Penny Lane, Walla Walla, WA 99362 Phone: 509-529-2130 Fax: 509-526-3640 | |
L. Jenae Henry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1644 Plaza Way # 302, Walla Walla, WA 99362 Phone: 509-876-8065 Fax: 877-560-9702 | |
Switchback Wellness, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5 W Alder St Ste 342, Walla Walla, WA 99362 Phone: 541-371-2511 Fax: 509-769-5452 | |
Teaming For Success Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 W Chestnut St, Walla Walla, WA 99362 Phone: 509-529-5133 Fax: 509-525-3442 | |
Sara Muckler Ma Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1337 Caprio Loop, Walla Walla, WA 99362 Phone: 206-605-6329 | |
Catherine J. Mehn, Licsw Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 W Main St Ste 101, Walla Walla, WA 99362 Phone: 509-301-0476 | |
Zimmerman Counseling Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 W Main St Ste 101, Walla Walla, WA 99362 Phone: 509-876-6987 |